Burden of Illness and Quality-of-Life Measures in Angioedema Conditions
- PMID: 28687112
- DOI: 10.1016/j.iac.2017.04.005
Burden of Illness and Quality-of-Life Measures in Angioedema Conditions
Abstract
Burden of illness studies and evaluation of health-related quality of life using validated questionnaires have become an important task in the comprehensive management of angioedema conditions, mainly angioedema associated with chronic spontaneous urticaria and hereditary angioedema caused by C1-inhibitor deficiency. A review of the principal tools and studies is presented. Both diseases present a higher proportion of psychiatric disorders, impair work and studies productivity, and produce high direct and indirect costs. These assessments also have been useful to evaluate the positive impact of new drugs and interventions. More studies are desirable, especially in other types of angioedema disorders, such as hereditary angioedema with normal C1 inhibitor.
Keywords: Angioedema; Anxiety; Burden; Depression; Health-related quality of life; Patient-reported outcomes; Quality of life.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema.Clin Rev Allergy Immunol. 2016 Oct;51(2):230-9. doi: 10.1007/s12016-016-8575-2. Clin Rev Allergy Immunol. 2016. PMID: 27388236 Review.
-
Quality of life in patients with urticaria and angioedema: assessing burden of disease.Allergy Asthma Proc. 2014 Jan-Feb;35(1):4-9. doi: 10.2500/aap.2014.35.3713. Allergy Asthma Proc. 2014. PMID: 24433591 Review.
-
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9. Clin Exp Immunol. 2017. PMID: 27936514 Free PMC article.
-
How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both.J Allergy Clin Immunol Pract. 2021 Jun;9(6):2151-2157. doi: 10.1016/j.jaip.2021.02.026. J Allergy Clin Immunol Pract. 2021. PMID: 34112471
-
Clinical Measures of Chronic Urticaria.Immunol Allergy Clin North Am. 2017 Feb;37(1):35-49. doi: 10.1016/j.iac.2016.08.005. Epub 2016 Nov 1. Immunol Allergy Clin North Am. 2017. PMID: 27886909 Review.
Cited by
-
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report.Allergy Asthma Clin Immunol. 2021 Apr 19;17(1):40. doi: 10.1186/s13223-021-00537-2. Allergy Asthma Clin Immunol. 2021. PMID: 33875020 Free PMC article. Review.
-
Therapeutic management of hereditary angioedema: past, present, and future.Balkan Med J. 2021 Mar;38(2):89-103. doi: 10.5152/balkanmedj.2021.21094. Balkan Med J. 2021. PMID: 33724190 Free PMC article.
-
The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews.Orphanet J Rare Dis. 2022 Jun 16;17(1):232. doi: 10.1186/s13023-022-02360-3. Orphanet J Rare Dis. 2022. PMID: 35710442 Free PMC article. Review.
-
Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).Orphanet J Rare Dis. 2022 Mar 2;17(1):88. doi: 10.1186/s13023-022-02202-2. Orphanet J Rare Dis. 2022. PMID: 35236380 Free PMC article.
-
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar. World Allergy Organ J. 2022. PMID: 35497649 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources